FindTrial
Sign In

Comparable efficacy of prucalopride and 2-L PEG versus 2-L PEG for bowel preparation in colonoscopy - Randomized controlled trial

Comparable efficacy of prucalopride and 2-L PEG versus 2-L PEG for bowel preparation in colonoscopy - Randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200411003
Enrollment
162
Registered
2020-04-11
Start date
2018-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel preparation Prucalopride&#44

Interventions

Prokinetic agent,No
No Intervention Drug,No Intervention No treatment
Prucalopride,No intervention

Sponsors

Phramongkutklao hospital
Lead Sponsor
Phramongkutklao hospital
Collaborator

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 50-85 years 2. Elective colonoscopy

Exclusion criteria

Exclusion criteria: 1. IBD 2. diverticulum 3. Allegy to prucalopride 4. CKD stage 4 5. Morbid obesity 6. Opiod use

Design outcomes

Primary

MeasureTime frame
Efficacy of prucalopride No Bowel preparation score—

Secondary

MeasureTime frame
compare the safety of adjunctive prucalopride for bowel preparation before colonoscopy. No Bowel preparation score—

Countries

Thailand

Contacts

Public ContactPongpan Boonmeeseeprasert

027639300

pongpanmd77@gmail.com0814107583

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026